# Aripiprazole IM Depot for Chinese Patients With Schizophrenia

> **NCT03287505** · PHASE1 · COMPLETED · sponsor: **Otsuka Beijing Research Institute** · enrollment: 24 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** Aripiprazole IM Depot

## Key facts

- **NCT ID:** NCT03287505
- **Lead sponsor:** Otsuka Beijing Research Institute
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-23
- **Primary completion:** 2019-11-08
- **Final completion:** 2019-11-08
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2020-12-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03287505

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03287505, "Aripiprazole IM Depot for Chinese Patients With Schizophrenia". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03287505. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*